Pharma
How pharma may be affected by Medicare drug price negotiations
Pharma companies have warned that the lowered prices will mean less drug innovation.
Pharma companies have warned that the lowered prices will mean less drug innovation.
And Ozempic is at the top of the list.
As of January 1, Medicare Part D enrollees will spend less than $2,000 out of pocket per year on their medications.
New year, same drama.
The administration proposed allowing Medicare and Medicaid to cover the drugs for weight loss, not just diabetes and cardiovascular disease.
With the new year around the corner, two hospital experts make their predictions for 2025.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.